Related Experiment Video

Updated: Aug 14, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Atrial fibrillation ablation in the real world

F R Quinn, A C Rankin

    Heart (British Cardiac Society)
    |November 17, 2005
    PubMed

    Abstract:

    While the potential for curative treatment of atrial fibrillation has generated much interest in the role of catheter ablation, its widespread use has been limited by a number of factors.

    More Related Videos

    Robotic Ablation of Atrial Fibrillation
    11:21

    Robotic Ablation of Atrial Fibrillation

    Published on: May 29, 2015

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
    28:13

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

    Published on: February 26, 2013

    Related Experiment Videos

    Last Updated: Aug 14, 2026

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
    10:46

    Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

    Published on: May 26, 2015

    Robotic Ablation of Atrial Fibrillation
    11:21

    Robotic Ablation of Atrial Fibrillation

    Published on: May 29, 2015

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
    28:13

    Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

    Published on: February 26, 2013

    Related Concept Videos

    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    Disturbances in Heart Rhythm01:29

    Disturbances in Heart Rhythm

    Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
    Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

    Articles linked to this work by shared authors, journal, and citation graph.

    Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study.

    Journal of electrocardiology·2019

    Spontaneous Ca2+ transients in rat pulmonary vein cardiomyocytes are increased in frequency and become more synchronous following electrical stimulation.

    Cell calcium·2018

    Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.

    The journal of the Royal College of Physicians of Edinburgh·2016

    Clinically important atrial arrhythmia and stroke risk: a UK-wide online survey among stroke physicians and cardiologists.

    QJM : monthly journal of the Association of Physicians·2014

    An in vitro model for the pro-fibrotic effects of retinoids: mechanisms of action.

    British journal of pharmacology·2013

    Transient outward K+ current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes.

    The Journal of physiology·2012

    Atrial fibrillation and coronary artery disease: interactions, outcomes and evolving management strategies.

    Heart (British Cardiac Society)·2026

    Sex differences in early ventricular fibrillation among patients with fulminant myocarditis in a nationwide registry.

    Heart (British Cardiac Society)·2026

    Post-heart transplantation immunosuppression and rejection: what the general cardiologist needs to know.

    Heart (British Cardiac Society)·2026

    Permanent pacemaker implantation after cardiac surgery and long-term outcome.

    Heart (British Cardiac Society)·2026

    Prospective evaluation of a self-report-guided strategy for targeted coronary artery calcium imaging.

    Heart (British Cardiac Society)·2026

    European Infective Endocarditis (EURO-ENDO) score for predicting 30-day mortality in left-sided infective endocarditis.

    Heart (British Cardiac Society)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us